85 related articles for article (PubMed ID: 11605135)
1. Age-dependent myocardial reinduction of apoptosis inhibitors under VAD in heart failure.
Scheubel RJ; Bartling B; Stein S; Darmer D; Holtz J; Pregla R; Hetzer R; Koerfer R; Zerkowski HR; Silber RE
Thorac Cardiovasc Surg; 2001 Oct; 49(5):268-72. PubMed ID: 11605135
[TBL] [Abstract][Full Text] [Related]
2. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure.
Bartling B; Milting H; Schumann H; Darmer D; Arusoglu L; Koerner MM; El-Banayosy A; Koerfer R; Holtz J; Zerkowski HR
Circulation; 1999 Nov; 100(19 Suppl):II216-23. PubMed ID: 10567307
[TBL] [Abstract][Full Text] [Related]
3. Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.
Milting H; Scholz C; Arusoglu L; Freitag M; Cebulla R; Jaquet K; Körfer R; V Lewinski D; Kassner A; Brodde OE; Kögler H; El Banayosy A; Pieske B
J Mol Cell Cardiol; 2006 Sep; 41(3):441-50. PubMed ID: 16765375
[TBL] [Abstract][Full Text] [Related]
4. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
5. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
7. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
[TBL] [Abstract][Full Text] [Related]
8. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.
Patten RD; Denofrio D; El-Zaru M; Kakkar R; Saunders J; Celestin F; Warner K; Rastegar H; Khabbaz KR; Udelson JE; Konstam MA; Karas RH
J Am Coll Cardiol; 2005 May; 45(9):1419-24. PubMed ID: 15862412
[TBL] [Abstract][Full Text] [Related]
9. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.
Wang J; Tsukashita M; Nishina T; Marui A; Yoshikawa E; Muranaka H; Matsuoka S; Ikeda T
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):465-70. PubMed ID: 19185171
[TBL] [Abstract][Full Text] [Related]
10. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure.
Morawietz H; Szibor M; Goettsch W; Bartling B; Barton M; Shaw S; Koerfer R; Zerkowski HR; Holtz J
Circulation; 2000 Nov; 102(19 Suppl 3):III188-93. PubMed ID: 11082385
[TBL] [Abstract][Full Text] [Related]
11. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
12. Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support.
Schwientek P; Ellinghaus P; Steppan S; D'Urso D; Seewald M; Kassner A; Cebulla R; Schulte-Eistrup S; Morshuis M; Röfe D; El Banayosy A; Körfer R; Milting H
Physiol Genomics; 2010 Aug; 42(3):397-405. PubMed ID: 20460602
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart.
Wohlschlaeger J; Levkau B; Brockhoff G; Schmitz KJ; von Winterfeld M; Takeda A; Takeda N; Stypmann J; Vahlhaus C; Schmid C; Pomjanski N; Böcking A; Baba HA
Circulation; 2010 Mar; 121(8):989-96. PubMed ID: 20159834
[TBL] [Abstract][Full Text] [Related]
14. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A
J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398
[TBL] [Abstract][Full Text] [Related]
15. Partial left ventricular unloading reverses contractile dysfunction and helps recover gene expressions in failing rat hearts.
Wang J; Marui A; Ikeda T; Komeda M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):27-31. PubMed ID: 18006556
[TBL] [Abstract][Full Text] [Related]
16. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
Kong YH; Li WM; Tian Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
[TBL] [Abstract][Full Text] [Related]
17. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
[TBL] [Abstract][Full Text] [Related]
18. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
Madigan JD; Barbone A; Choudhri AF; Morales DL; Cai B; Oz MC; Burkhoff D
J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
[TBL] [Abstract][Full Text] [Related]
19. Influence of Mechanical Circulatory Support on Endothelin Receptor Expression in Human Left Ventricular Myocardium from Patients with Dilated Cardiomyopathy (DCM).
Gärtner F; Abraham G; Kassner A; Baurichter D; Milting H
PLoS One; 2017; 12(1):e0169896. PubMed ID: 28095452
[TBL] [Abstract][Full Text] [Related]
20. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
